Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody

Clin Exp Dermatol. 2021 Dec;46(8):1586-1588. doi: 10.1111/ced.14789. Epub 2021 Jun 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use*
  • Adult
  • Cellulitis / complications
  • Cellulitis / drug therapy*
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Male
  • Scalp Dermatoses / complications
  • Scalp Dermatoses / drug therapy*
  • Skin Diseases, Genetic / complications
  • Skin Diseases, Genetic / drug therapy*
  • Tumor Necrosis Factor Inhibitors / therapeutic use*

Substances

  • Tumor Necrosis Factor Inhibitors
  • Adalimumab

Supplementary concepts

  • Perifolliculitis Capitis Abscedens Et Suffodiens, Familial